Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock is trading -61.45 percent below its 52-week high
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
What are the chances of Adaptive Biotechnologies Corp (ADPT) Stock turning the corner?
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
Why Adaptive Biotechnologies Corp (NASDAQ:ADPT) Stock declined -33.41% in Last Three Months?
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
Are there any attempts to gain ground? Adaptive Biotechnologies Corp (ADPT) Stock
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
Will Earnings Beat Estimates? Adaptive Biotechnologies Corp (ADPT) Stock
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
It’s not the right time to quit: Adaptive Biotechnologies Corp (ADPT) Stock
JP Morgan raised the price target for the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock to “an Overweight”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $14. The stock was initiated by Credit Suisse, […]
